Year-End Report

DOW LOHNES GOVERNMENT STRATEGIES LLC for APOTEX CORP

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$40,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Report (this page) Feb 14, 2008 $40,000 Replaced
Year-End Amendment Mar 18, 2008 $40,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 3700 Fair Medicaid Drug Payment Act of 2007, regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety

LobbyistCovered position, as disclosed
ERIC S KESSLER CHIEF OF STAFF, HON. JOHN D. DINGELL
KENNETH D SALOMON N/A
STEPHEN C SAYLE N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3610 (110th), H.R. 3700 (110th), H.R. 1902 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.